Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Mutel, V' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 43 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pinard, E; Alanine, A; Bourson, A; Buttelmann, B; Gill, R; Heitz, MP; Jaeschke, G; Mutel, V; Trube, G; Wyler, R
      Discovery of (R)-1-[2-Hydroxy-3-(4-hydroxy-phenyl)-propyl]-4-(4-methyl-benzyl)-piperidin-4-ol: A novel NR1/2B subtype selective NMDA receptor antagonist

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    2. Knoflach, F; Woltering, T; Adam, G; Mutel, V; Kemp, JA
      Pharmacological properties of native metabotropic glutamate receptors in freshly dissociated Golgi cells of the rat cerebellum

      NEUROPHARMACOLOGY
    3. Kew, JNC; Ducarre, JM; Pflimlin, MC; Mutel, V; Kemp, JA
      Activity-dependent presynaptic autoinhibition by group II metabotropic glutamate receptors at the perforant path inputs to the dentate gyrus and CA1

      NEUROPHARMACOLOGY
    4. Knoflach, F; Mutel, V; Kew, JNC; Malherbe, P; Vieira, E; Wichmann, J; Kemp, JA
      Positive allosteric modulators of metabotropic glutamate 1 receptor: Characterization, mechanism of action, and binding site

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    5. Malherbe, P; Knoflach, F; Broger, C; Ohresser, S; Kratzeisen, C; Adam, G; Stadler, H; Kemp, JA; Mutel, V
      Identification of essential residues involved in the glutamate binding pocket of the group II metabotropic glutamate receptor

      MOLECULAR PHARMACOLOGY
    6. Lynch, DR; Shim, SS; Seifert, KM; Kurapathi, S; Mutel, V; Gallagher, MJ; Guttmann, RP
      Pharmacological characterization of interactions of RO 25-6981 with the NR2B (epsilon 2) subunit

      EUROPEAN JOURNAL OF PHARMACOLOGY
    7. Kew, JNC; Koester, A; Moreau, JL; Jenck, F; Ouagazzal, AM; Mutel, V; Richards, JG; Trube, G; Fischer, G; Montkowski, A; Hundt, W; Reinscheid, RK; Pauly-Evers, M; Kemp, JA; Bluethmann, H
      Functional consequences of reduction in NMDA receptor glycine affinity in mice carrying targeted point mutations in the glycine binding site

      JOURNAL OF NEUROSCIENCE
    8. Schweitzer, C; Kratzeisen, C; Adam, G; Lundstrom, K; Malherbe, P; Ohresser, S; Stadler, H; Wichmann, J; Woltering, T; Mutel, V
      Characterization of [H-3]-LY354740 binding to rat mGlu2 and mGlu3 receptors expressed in CHO cells using Semliki Forest virus vectors

      NEUROPHARMACOLOGY
    9. Mutel, V; Ellis, GJ; Adam, G; Chaboz, S; Nilly, A; Messer, J; Bleuel, Z; Metzler, V; Malherbe, P; Schlaeger, EJ; Roughley, BS; Faull, RLM; Richards, JG
      Characterization of [H-3]quisqualate binding to recombinant rat metabotropic glutamate 1a and 5a receptors and to rat and human brain sections

      JOURNAL OF NEUROCHEMISTRY
    10. Mouillet-Richard, S; Mutel, V; Loric, S; Tournois, C; Launay, JM; Kellermann, O
      Regulation by neurotransmitter receptors of serotonergic or catecholaminergic neuronal cell differentiation

      JOURNAL OF BIOLOGICAL CHEMISTRY
    11. Copani, A; Romano, C; Gerevinia, VD; Nicosia, A; Casabona, G; Storto, M; Mutel, V; Nicoletti, F
      Reducing conditions differentially affect the functional and structural properties of group-I and -II metabotropic glutamate receptors

      BRAIN RESEARCH
    12. Kolczewski, S; Adam, G; Stadler, H; Mutel, V; Wichmann, J; Woltering, T
      Synthesis of heterocyclic enol ethers and their use as group 2 metabotropic glutamate receptor antagonists

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    13. Wichmann, J; Adam, G; Kolczewski, S; Mutel, V; Woltering, T
      Structure-activity relationships of substituted 5H-thiazolo [3,2-a]pyrimidines as group 2 metabotropic glutamate receptor antagonists

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    14. Malherbe, P; Kratzeisen, C; Lundstrom, K; Richards, JG; Faull, RLM; Mutel, V
      Cloning and functional expression of alternative spliced variants of the human metabotropic glutamate receptor 8

      MOLECULAR BRAIN RESEARCH
    15. Mutel, V
      The mission of the Church at the turn of the year 2000

      ETUDES THEOLOGIQUES ET RELIGIEUSES
    16. Monastyrskaia, K; Lundstrom, K; Plahl, D; Acuna, G; Schweitzer, C; Malherbe, P; Mutel, V
      Effect of the umami peptides on the ligand binding and function of rat mGlu4a receptor might implicate this receptor in the monosodium glutamate taste transduction

      BRITISH JOURNAL OF PHARMACOLOGY
    17. KEW JNC; RICHARDS JG; MUTEL V; KEMP JA
      DEVELOPMENTAL-CHANGES IN NMDA RECEPTOR GLYCINE AFFINITY AND IFENPRODIL SENSITIVITY REVEAL 3 DISTINCT POPULATIONS OF NMDA RECEPTORS IN INDIVIDUAL RAT CORTICAL-NEURONS

      The Journal of neuroscience
    18. SCHAFFHAUSER H; RICHARDS JG; CARTMELL J; CHABOZ S; KEMP JA; KLINGELSCHMIDT A; MESSER J; STADLER H; WOLTERING T; MUTEL V
      IN-VITRO BINDING CHARACTERISTICS OF A NEW SELECTIVE GROUP-II METABOTROPIC GLUTAMATE-RECEPTOR RADIOLIGAND, [H-3]LY354740, IN RAT-BRAIN

      Molecular pharmacology
    19. MARTIN JR; BOS M; JENCK F; MOREAU JL; MUTEL V; SLEIGHT AJ; WICHMANN J; ANDREWS JS; BERENDSEN HHG; BROEKKAMP CLE; RUIGT GSF; KOHLER C; VANDELFT AML
      5-HT2C RECEPTOR AGONISTS - PHARMACOLOGICAL CHARACTERISTICS AND THERAPEUTIC POTENTIAL

      The Journal of pharmacology and experimental therapeutics
    20. MUTEL V; ADAM G; CHABOZ S; KEMP JA; KLINGELSCHMIDT A; MESSER J; WICHMANN J; WOLTERING T; RICHARDS JG
      CHARACTERIZATION OF (2S,2'R,3'R)-2-(2',3'-[H-3]-DICARBOXYCYCLOPROPYL)GLYCINE BINDING IN RAT-BRAIN

      Journal of neurochemistry
    21. MUTEL V; TRUBE G; KLINGELSCHMIDT A; MESSER J; BLEUEL Z; HUMBEL U; CLIFFORD MM; ELLIS GJ; RICHARDS JG
      BINDING CHARACTERISTICS OF A POTENT AMPA RECEPTOR ANTAGONIST [H-3]RO-48-8587 IN RAT-BRAIN

      Journal of neurochemistry
    22. LUNDSTROM K; KNOFLACH F; GOEPFERT F; SCHAFFHAUSER H; PINK JR; BORER Y; ZILTENER P; MUTEL V; HOFFMANNLAROCHE F
      FUNCTIONAL EXPRESSION OF METABOTROPIC GLUTAMATE RECEPTORS IN PRIMARY NEURONS INFECTED WITH SEMLIKI-FOREST-VIRUS VECTORS

      Journal of neurochemistry
    23. MUTEL V; BUCHY D; KLINGELSCHMIDT A; MESSER J; BLEUEL Z; KEMP JA; RICHARDS JG
      IN-VITRO BINDING-PROPERTIES IN RAT-BRAIN OF [H-3]RO-25-6981, A POTENTAND SELECTIVE ANTAGONIST OF NMDA RECEPTORS CONTAINING NR2B SUBUNITS

      Journal of neurochemistry
    24. TOURNOIS C; MUTEL V; MANIVET P; LAUNAY JM; KELLERMANN O
      CROSS-TALK BETWEEN 5-HYDROXYTRYPTAMINE RECEPTORS IN A SEROTONERGIC CELL-LINE - INVOLVEMENT OF ARACHIDONIC-ACID METABOLISM

      The Journal of biological chemistry
    25. CARTMELL J; ADAM G; CHABOZ S; HENNINGSEN R; KEMP JA; KLINGELSCHMIDT A; METZLER V; MONSMA F; SCHAFFHAUSER H; WICHMANN J; MUTEL V
      CHARACTERIZATION OF (2S,2'R,3'R)-2-(2',3'-DICARBOXYCYCLOPROPYL)GLYCINE ([H-3]-DCG-IV) BINDING TO METABOTROPIC MGLU(2) RECEPTOR-TRANSFECTED CELL-MEMBRANES

      British Journal of Pharmacology
    26. RICHARDS JG; SCHAFFHAUSER H; MESSER J; BLEUEL Z; CHABOZ S; KLINGELSCHMIDT A; WICHMANN J; KEMP JA; MUTEL V
      IN-VITRO BINDING CHARACTERISTICS AND DISTRIBUTION OF THE GROUP-II METABOTROPIC RECEPTOR AGONIST [H-3]LY354740 IN RAT-BRAIN

      British Journal of Pharmacology
    27. CARTMELL J; GOEPFERT F; KNOFLACH F; PINK JR; BLEUEL Z; RICHARDS JG; SCHAFFHAUSER H; KEMP JA; WICHMANN J; MUTEL V
      EFFECT OF METABOTROPIC GLUTAMATE-RECEPTOR ACTIVATION ON RECEPTOR-MEDIATED CYCLIC-AMP RESPONSES IN PRIMARY CULTURES OF RAT STRIATAL NEURONS

      Brain research
    28. SCHAFFHAUSER H; KNOFLACH F; PINK JR; BLEUEL Z; CARTMELL J; GOEPFERT F; KEMP JA; RICHARDS JG; ADAM G; MUTEL V
      MULTIPLE PATHWAYS FOR REGULATION OF THE KCL-INDUCED [H-3]-GABA RELEASE BY METABOTROPIC GLUTAMATE RECEPTORS, IN PRIMARY RAT CORTICAL CULTURES

      Brain research
    29. CARTMELL J; KEMP JA; MUTEL V
      L-AP4 INHIBITION OF DEPOLARIZATION-EVOKED CGMP FORMATION IN RAT CEREBELLUM

      Neuroscience letters
    30. BOS M; JENCK F; MARTIN JR; MOREAU JL; MUTEL V; SLEIGHT AJ; WIDMER U
      SYNTHESIS, PHARMACOLOGY AND THERAPEUTIC POTENTIAL OF 10-METHOXYPYRAZINO[1,2-A]INDOLES, PARTIAL AGONISTS AT THE 5HT(2C) RECEPTOR

      European journal of medicinal chemistry
    31. SCHAFFHAUSER H; CARTMELL J; JAKOBROTNE R; MUTEL V
      PHARMACOLOGICAL CHARACTERIZATION OF METABOTROPIC GLUTAMATE RECEPTORS LINKED TO THE INHIBITION OF ADENYLATE-CYCLASE ACTIVITY IN RAT STRIATALSLICES

      Neuropharmacology
    32. FISCHER G; MUTEL V; TRUBE G; MALHERBE P; KEW JNC; MOHACSI E; HEITZ MP; KEMP JA
      RO-25-6981, A HIGHLY POTENT AND SELECTIVE BLOCKER OF N-METHYL-D-ASPARTATE RECEPTORS CONTAINING THE NR2B SUBUNIT - CHARACTERIZATION IN-VITRO

      The Journal of pharmacology and experimental therapeutics
    33. SCHAFFHAUSER H; DEBARRY J; MULLER H; HEITZ MP; GOMBOS G; MUTEL V
      INVOLVEMENT OF A CYCLIC-AMP PATHWAY IN GROUP-I METABOTROPIC GLUTAMATE-RECEPTOR RESPONSES IN NEONATAL RAT CORTEX

      European journal of pharmacology
    34. RICHARDS JG; MESSER J; BLEUEL Z; MALHERBE P; KLINGELSCHMIDT A; CLIFFORD MM; ELLIS GJ; MUTEL V
      IN-VITRO BINDING CHARACTERISTICS OF A POTENT, SELECTIVE AMPA RECEPTORANTAGONIST, [H-3] RO-48-8587, IN RAT-BRAIN

      British Journal of Pharmacology
    35. CARTMELL J; SCHAFFHAUSER H; WICHMANN J; MUTEL V
      MGLUR-EVOKED AUGMENTATION OF RECEPTOR-MEDIATED CYCLIC-AMP FORMATION IN NEONATAL AND ADULT-RAT STRIATUM

      British Journal of Pharmacology
    36. RICHARDS JG; MESSER J; BUCHY D; KLINGELSCHMIDT A; MUTEL V
      IN-VITRO BINDING CHARACTERISTICS OF A SELECTIVE NMDA RECEPTOR 2(B) SUBTYPE ANTAGONIST [H-3] RO-25-6981 IN RAT-BRAIN

      British Journal of Pharmacology
    37. SLEIGHT AJ; STAM NJ; MUTEL V; VANDERHEYDEN PML
      RADIOLABELING OF THE HUMAN 5-HT2A RECEPTOR WITH AN AGONIST, A PARTIALAGONIST AND AN ANTAGONIST - EFFECTS ON APPARENT AGONIST AFFINITIES

      Biochemical pharmacology
    38. KANNENGIESER C; BOUAZZAOUI M; DEBARRY J; PROCKSCH O; GOMBOS G; MUTEL V; SCHAFFAUSER H
      METABOTROPIC EFFECT OF GLUTAMATE IONOTROPIC AGONISTS AND UPTAKE INHIBITORS IN CEREBELLAR SLICES

      Journal of neurochemistry
    39. GRIEBEL G; MOREAU JL; JENCK F; MUTEL V; MARTIN JR; MISSLIN R
      EVIDENCE THAT TOLERANCE TO THE ANXIOGENIC-LIKE EFFECTS OF MCPP DOES NOT INVOLVE ALTERATION IN THE FUNCTION OF 5-HT2C RECEPTORS IN THE RAT CHOROID-PLEXUS

      Behavioural pharmacology
    40. BORRONI E; DAMSMA G; GIOVACCHINI C; MUTEL V; JAKOBROTNE R; DAPRADA M
      A NOVEL ACETYLCHOLINESTERASE INHIBITOR, RO-46-5934, WHICH INTERACTS WITH MUSCARINIC M2 RECEPTORS

      Biochemical Society transactions
    41. JENCK F; MOREAU JL; MUTEL V; MARTIN JR
      BRAIN 5-HT1C RECEPTORS AND ANTIDEPRESSANTS

      Progress in neuro-psychopharmacology & biological psychiatry
    42. LAUNAY JM; BONDOUX D; OSETGASQUE MJ; EMAMI S; MUTEL V; HAIMART M; GESPACH C
      INCREASE OF HUMAN PLATELET SEROTONIN UPTAKE BY ATYPICAL HISTAMINE-RECEPTORS

      The American journal of physiology
    43. FRANCOIS J; MOREAU JL; MUTEL V; MARTIN JR
      DEPRESSION, CHRONIC MILD STRESS AND BRAIN 5-HT(1C) RECEPTORS

      Neuropsychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 15:21:20